Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo (D5W)
DRUG
4 trials
Sponsors
British Columbia Cancer Agency
, University of Virginia
, Melinta Therapeutics, Inc.
, The Medicines Company
Conditions
Apnea
Bradycardia
Cancer-related Pain
Gastroesophageal Reflux
Healthy
Skin Diseases, Bacterial
Phase 1
Multiple Oritavancin Doses on Safety, Tolerability, and Pharmacokinetics in Healthy Subjects
Completed
NCT02470702
Melinta Therapeutics, Inc.
Healthy
Start: 2015-06-30
End: 2015-10-31
Updated: 2023-12-19
Phase 2
Subcutaneous Lidocaine For Cancer-Related Pain
Completed
NCT01384877
British Columbia Cancer Agency
Cancer-related Pain
Start: 2011-12-31
End: 2019-01-31
Updated: 2019-07-12
Phase 4
Safety of Either a Single or Two Intravenous Doses of Orbactiv in Participants With Acute Bacterial Skin and Skin Structure Infection
Completed
NCT02925416
The Medicines Company
Skin Diseases, Bacterial
Start: 2017-01-24
End: 2017-06-20
Updated: 2024-02-01
Unknown Phase
Study of Erythromycin in GER-Associated Apnea of the Newborn
NCT01825473
University of Virginia
Apnea, Bradycardia, Gastroesophageal Reflux
Start: 2012-09-30
End: 2014-06-30
Target: 40
Updated: 2013-04-05